[Mechanism of the protective effect of dalargin on development of ischemic heart arrhythmias].
Mikhaĭlova
S D
SD
Storozhakov
G I
GI
Bebiakova
N A
NA
Semushkina
T M
TM
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D017202:Myocardial Ischemia / Q000150:complications* / Q000503:physiopathology; D013562:Sympathectomy; D013565:Sympatholytics / Q000494:pharmacology*; D014693:Ventricular Fibrillation / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*
D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
K mekhanizmy protektivnogo deĭstviia dalargina na razvitie ishemicheskikh aritmiĭ serdtsa.